BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 3871412)

  • 1. Corticotropin-releasing factor and behavior.
    Koob GF; Bloom FE
    Fed Proc; 1985 Jan; 44(1 Pt 2):259-63. PubMed ID: 3871412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF; Thatcher-Britton K
    Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological actions of corticotropin-releasing factor in the central nervous system.
    Siggins GR; Gruol D; Aldenhoff J; Pittman Q
    Fed Proc; 1985 Jan; 44(1 Pt 2):237-42. PubMed ID: 3155696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures.
    Blatchford KE; Choi EA; McNally GP
    Behav Neurosci; 2006 Oct; 120(5):1169-74. PubMed ID: 17014268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys.
    Kalin NH
    Fed Proc; 1985 Jan; 44(1 Pt 2):249-53. PubMed ID: 3871411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
    Kalivas PW; Duffy P; Latimer LG
    J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine.
    Erb S; Brown ZJ
    Behav Brain Res; 2006 Sep; 172(2):360-4. PubMed ID: 16822557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats.
    Ohmura Y; Yamaguchi T; Futami Y; Togashi H; Izumi T; Matsumoto M; Yoshida T; Yoshioka M
    Behav Brain Res; 2009 Mar; 198(2):429-33. PubMed ID: 19084036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
    Salak-Johnson JL; Anderson DL; McGlone JJ
    Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
    Sajdyk TJ; Fitz SD; Shekhar A
    Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocortical power spectrum changes induced by microinfusion of corticotropin-releasing factor into the locus coeruleus in rats.
    De Sarro GB; Fratta W; Giglio A; Nisticò G
    Funct Neurol; 1992; 7(5):407-12. PubMed ID: 1292962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
    Yang XM; Gorman AL; Dunn AJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1064-70. PubMed ID: 2262892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
    Ohata H; Shibasaki T
    Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats.
    Lowry CA; Hale MW; Plant A; Windle RJ; Shanks N; Wood SA; Ingram CD; Renner KJ; Lightman SL; Summers CH
    Stress; 2009 May; 12(3):225-39. PubMed ID: 18951247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1).
    Al Chawaf A; Xu K; Tan L; Vaccarino FJ; Lovejoy DA; Rotzinger S
    Peptides; 2007 Jul; 28(7):1406-15. PubMed ID: 17644218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
    Erb S; Funk D; Lê AD
    Neurosci Lett; 2005 Aug; 383(3):209-14. PubMed ID: 15955413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioural and electrophysiological effects of CRF in rat frontal cortex.
    Zieba B; Grzegorzewska M; Brański P; Domin H; Wierońska JM; Hess G; Smiałowska M
    Neuropeptides; 2008; 42(5-6):513-23. PubMed ID: 18617263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.